UNSPSC 51113205: Pumitepa

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51113205

Definition

This classification denotes an antineoplastic alkylating agent with the molecular formula C12H19N8OP, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7AYY495RE0, chemically known as p,p-bis(1-aziridinyl)-n-(2-(dimethylamino)-7-methylpurin-6-yl)phosphinic amide but more generally known as pumitepa, which bears US NIH Compound Identifier 68669. European Medicines Agency schedules Pumitepa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10160MIG.

Read the full definition

The term PUMITEPA is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). PUMITEPA is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule pumitepa under HS 29335995 and SITC 51576. As of Q4 2014, PUMITEPA remains US FDA's Preferred Term for this commodity. Pumitepa bears US NLM identifiers UMLS ID C0060632 and NCI Concept Code C73239. SMILES: CN1C=NC2=C1C(=NC(=N2)N(C)C)NP(=O)(N3CC3)N4CC4.

About UNSPSC 51113205

UNSPSC 51113205 Pumitepa, a Commodity code, names pharmaceutical products that state and local governments procure for health benefit programs and medicaid operations, with recent activity focused on direct-to-manufacturer prescription fulfillment models. The code captures state health agencies' procurement of pharmaceuticals and related pharmacy services, particularly where those agencies seek to bypass traditional pharmacy benefit managers, group purchasing organizations, or wholesalers and establish direct contracting relationships with drug manufacturers to manage cost and improve prescription fulfillment efficiency.

The Texas Health and Human Services Commission issued RFI No. HHS0017013 on March 27, 2026 (response deadline April 3, 2026) to solicit vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program. That RFI, the only recent opportunity in the source, sought comprehensive information from potential vendors about establishing direct relationships between the state's pharmacy benefit program and pharmaceutical manufacturers, including vendor experience with direct contracting for self-insured employers and health plans in both private and government sectors within the prior two years, flexibility to negotiate contracts based on negotiated net pricing models without rebates, and capability to implement value-based or outcomes-based agreements. The RFI did not specify set-aside designations, budget ranges, or award values, functioning as an exploratory market-intelligence mechanism to inform the state's future procurement strategy before issuing a formal RFP. No other state or local jurisdictions appear in recent solicitation records for this code.

Quick answers

What is UNSPSC 51113205?

UNSPSC 51113205 is Pumitepa, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51113205?

UNSPSC 51113205 maps to 1 NIGP code, 26910 Antineoplastic Agents.

On GovTribe

See everything under UNSPSC 51113205

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code